Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Empowering the future of aging research: XPRIZE Healthspan to sponsor ARDD 2025, the world's largest conference on aging research in the biopharmaceutical industry

2025-08-01

(Press-News.org) The University of Copenhagen is excited to announce XPRIZE Healthspan as Tier 5 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.

ARDD has grown to become the largest and most important conference in longevity biotechnology. Each year, ARDD brings together a unique mix of academic luminaries, biotech innovators, investors, top pharmaceutical executives, physicians, and related health care professionals to discuss the latest advancements in aging research and the event provides unique opportunities to connect with brilliant minds, fostering collaboration and showcasing groundbreaking research in the field.

“We are extremely honored to host Professors Meldal and Levitt at ARDD2025. Their Nobel prize winning discoveries have been instrumental for drug development and molecular design in part through modelling of proteins and molecules, and in part through the ability to easily create new molecules. It is therefore a great pleasure that they are joining our conference.” said Morten Scheibye-Knudsen, MD, Ph.D., University of Copenhagen.

“We are really excited for ARDD2025, especially with Nobel Laureates Morten Meldal and Michael Levitt joining us. Their groundbreaking contributions have had a lasting impact on drug discovery, and having them at the conference is sure to make it an unforgettable experience.” said Daniela Bakula, Ph.D., University of Copenhagen.

“For 12 years, the Aging Research and Drug Discovery (ARDD) forum grew in size and in quality. It became the world’s main platform for academia-pharma-startup-investor partnership and dialogue. In 2025, the conference will feature the Nobel laureates, pharmaceutical industry executives and healthcare delivery leaders. ARDD is a unique platform for advancing longevity biotechnology around the world.” said Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine.

“At ARDD we strive to highlight the cutting-edge research and clinical applications in a new discipline of healthy longevity medicine. Having Nobel laureates join and speak at the ARDD conference underscores the critical importance of grounding longevity science and medicine in evidence-based, scientifically rigorous approaches.” said Prof.Dr.Evelyne Bischof, the organizer of the Longevity Medicine Days.

Aging research has become a great platform for advancing drug discovery with blockbuster potential, with pharmaceutical leaders like Novartis, Biogen, and Eli Lilly actively supporting this transformative field. ARDD has established itself as the go-to venue where scientists and pharma companies collaborate, share insights, and launch aging-focused research initiatives. In 2024, industry leaders such as Eli Lilly, Novartis, Regeneron, Biogen, and Lundbeck presented their latest research at ARDD, highlighting the meeting's pivotal role in advancing healthspan and longevity science. Be part of ARDD 2025 and contribute to shaping the future of medicine.

For further information, images or interviews, please contact:

ardd@pharma.ai

About Aging Research for Drug Discovery Conference

At ARDD, leaders in the aging, longevity, and drug discovery field will describe the latest progress in the molecular, cellular and organismal basis of aging and the search for interventions. Furthermore, the meeting will include opinion leaders in AI to discuss the latest advances of this technology in the biopharmaceutical sector and how this can be applied to interventions. Notably, this year we will have a special day called Longevity Medicine Day, specifically for physicians where the leading-edge knowledge of clinical interventions for healthy longevity will be described. ARRD intends to bridge clinical, academic and commercial research and foster collaborations that will result in practical solutions to one of humanity's most challenging problems: aging. Our quest to extend the healthy lifespan of everyone on the planet.

END

ELSE PRESS RELEASES FROM THIS DATE:

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

2025-08-01

The University of Copenhagen is excited to announce Immortal Dragons as Tier 4 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online. Immortal Dragons is a purpose-driven longevity fund headquartered in Singapore, supporting 15+ portfolio companies in longevity and radical life extension technologies. Immortal Dragons values impact rather than economic return, supporting moonshot longevity startups in radical life extension, key areas include: Wholebody replacement, ...

Reporting guideline for chatbot health advice studies

2025-08-01

About The Article: The rise in chatbot health advice studies is accompanied by heterogeneity in reporting standards, impacting their interpretability. This article provides reporting recommendations for studies evaluating the performance of generative artificial intelligence (AI)–driven chatbots when summarizing clinical evidence and providing health advice. This article is being published jointly in Artificial Intelligence in Medicine, Annals of Family Medicine, BJS, BMC Medicine, BMJ Medicine, JAMA Network Open, The Lancet, NEJM-AI, and Surgical Endoscopy. Corresponding Author: To contact the corresponding ...

Announcing Mitra Bio as Tier 3 Sponsor of ARDD 2025

2025-08-01

The University of Copenhagen is excited to announce Mitra Bio as Tier 3 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online. “ARDD sits at the intersection of frontier longevity science and real-world impact—exactly where Mitra Bio wants to be,” said Shakiba Kaveh, PhD, co-founder & CEO of Mitra Bio. “By sponsoring this year’s meeting, we hope to support the longevity science community and share our insights ...

Study identifies global upswing in photosynthesis driven by land, offset by oceans

2025-08-01

Terrestrial plants drove an increase in global photosynthesis between 2003 and 2021, a trend partially offset by a weak decline in photosynthesis — the process of using sunlight to make food — among marine algae, according to a new study published in Nature Climate Change on Aug. 1. The findings could inform planetary health assessments, enhance ecosystem management, and guide climate change projections and mitigation strategies. Photosynthetic organisms — also known as primary producers — form the base of the food chain, making most life on Earth possible. Using ...

Study reports final clinical trial data for advanced kidney cancer treatment

2025-08-01

A two-drug combination for treating advanced kidney cancer had sustained and durable clinical benefit in more than five years of follow-up, according to a study published Aug. 1 in Nature Medicine. The study reports final clinical data and biomarker analyses from the Phase 3 KEYNOTE-426 trial, which compared the drug combination pembrolizumab plus axitinib versus the single drug sunitinib for patients with previously untreated advanced clear cell renal cell carcinoma, the most common type of kidney cancer. “KEYNOTE-426 was the first trial to combine a PD-1 ...

Antibiotic resistant bacteria found in malnourished children under five years old

2025-08-01

A new study led by researchers at the Ineos Oxford Institute for antimicrobial research (IOI) has found that antimicrobial resistant bacteria is spreading rapidly among children being treated for severe malnutrition in a hospital facility in Niger. The findings have been published today (1 August) in Nature Communications Globally 45 million children under the age of five are estimated to be severely malnourished. These children are also at a higher risk of developing life-threatening infections such as tuberculosis or sepsis due to their weakened immune systems. Working with Médecins Sans Frontières (Doctors Without Borders), researchers analysed over 3,000 ...

Study: Most US homes can save money and affordably weather blackouts with solar plus storage

2025-08-01

Most U.S. households could reduce their electricity costs and endure power outages by installing rooftop solar panels and battery packs, according to a new Stanford University study, though people may need to buy the equipment by Dec. 31. About 60% of families could reduce their electricity costs by 15% on average by installing a solar-battery system. That’s after accounting for annualized capital and operating costs of the equipment. Some 63% of U.S households could also weather local or regional blackouts with such systems, able to meet about half their electricity needs on average. These households would either save money on electricity or ...

The human touch of doctors will still be needed in the AI healthcare revolution, technology expert suggests

2025-08-01

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele Caligiore, uses the latest science research to highlight key innovations assisted by AI such as diagnostic imaging and surgical robots. From exoskeletons that help spinal injury patients walk to algorithms that can predict the onset of dementia years in advance, Caligiore explores what he describes as a ‘revolution’ ...

Helping me, inhibiting you: Analysis of interactions between intestinal microbiota

2025-08-01

Intestinal bacteria are important for human health as they help digest food and regulate immune function. Thus, in recent years, it has become clear that gut microbiota dysbiosis, an imbalance in types and composition of intestinal bacteria, is associated with digestive disorders and other diseases. However, the mechanism by which bacteria interact in the intestine to maintain the microbiota balance remains unclear. A research group led by Associate Professor Koji Hosomi at Osaka Metropolitan University’s Graduate School of Veterinary Science studied two bacteria: Fusobacterium varium (F. varium), an oral and intestinal bacterium linked to inflammation and colon ...

Hearing loss lowers prospects of employment and higher income for young Americans

2025-08-01

Hearing loss is the most common form of sensory disability. Approximately 1.6 billion people around the world currently live with from some degree of hearing loss, and the WHO has forecast that this number will rise to 2.5 billion by 2050. People with hearing loss tend to experience more stress and anxiety at school or work, and as a result take more days off sick. The annual global cost of unaddressed hearing loss may run to $1 trillion. Now, a long-term observational study has found that young adults with hearing difficulties in the US have less educational ...

LAST 30 PRESS RELEASES:

UVA’s Jundong Li wins ICDM’S 2025 Tao Li Award for data mining, machine learning

UVA’s low-power, high-performance computer power player Mircea Stan earns National Academy of Inventors fellowship

Not playing by the rules: USU researcher explores filamentous algae dynamics in rivers

Do our body clocks influence our risk of dementia?

Anthropologists offer new evidence of bipedalism in long-debated fossil discovery

Safer receipt paper from wood

Dosage-sensitive genes suggest no whole-genome duplications in ancestral angiosperm

First ancient human herpesvirus genomes document their deep history with humans

Why Some Bacteria Survive Antibiotics and How to Stop Them - New study reveals that bacteria can survive antibiotic treatment through two fundamentally different “shutdown modes”